BioCorRx CEO, Brady Granier, Appears on Fox & Friends to Discuss the Opioid Epidemic
Jan 02, 2018 12:30 pm UTC| Business
ANAHEIM, CA, Jan. 02, 2018 -- BioCorRx Inc. (OTCQB: BICX) (the "Company"), a developer and provider of advanced solutions in the treatment of alcohol and opioid addictions, today announced that Brady Granier, BioCorRx...
Agios to Present at the 36th Annual J.P. Morgan Healthcare Conference on Monday, January 8, 2018
Jan 02, 2018 12:30 pm UTC| Business
CAMBRIDGE, Mass., Jan. 02, 2018 -- Agios Pharmaceuticals, Inc. (NASDAQ:AGIO), a leader in the field of cellular metabolism to treat cancer and rare genetic diseases, today announced the company is scheduled to present...
Aptose Biosciences to Present at Biotech Showcase™ 2018 Conference
Jan 02, 2018 12:30 pm UTC| Business
SAN DIEGO and TORONTO, Jan. 02, 2018 -- Aptose Biosciences Inc. (Nasdaq:APTO) (TSX:APS), a clinical-stage company developing highly differentiated therapeutics that target the underlying mechanisms of cancer, today...
Spark Therapeutics to Participate in Multiple Conferences in January
Jan 02, 2018 12:30 pm UTC| Business
PHILADELPHIA, Jan. 02, 2018 -- Spark Therapeutics (NASDAQ:ONCE), a fully integrated gene therapy company dedicated to challenging the inevitability of genetic disease, today announced that Jeffrey D. Marrazzo, chief...
The Community Financial Corporation Announces Completion of County First Bank Acquisition
Jan 02, 2018 12:30 pm UTC| Business
WALDORF, Md., Jan. 02, 2018 -- The Community Financial Corporation (NASDAQ:TCFC), the holding company for Community Bank of the Chesapeake, today announced that effective January 1, 2018, it has completed its...
Jan 02, 2018 12:30 pm UTC| Business
NEW YORK, Jan. 02, 2018 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Pieris...
Merus to Present at the 36th Annual J.P. Morgan Healthcare Conference
Jan 02, 2018 12:30 pm UTC| Business
UTRECHT, The Netherlands, Jan. 02, 2018 -- Merus N.V. (NASDAQ:MRUS), a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics, today announced that Ton Logtenberg, Ph.D., Chief...